Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2005
05/12/2005WO2005042006A2 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005WO2005042005A1 Amino acid composition with increased blood brain barrier permeability
05/12/2005WO2005041982A1 Combination therapy of peptide vaccination and estramustine treatment
05/12/2005WO2005041981A1 Combination therapy of peptide vaccination and estramustine treatment
05/12/2005WO2005041890A2 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
05/12/2005WO2005041877A2 Method of inhibiting rejection following organ transplantation
05/12/2005WO2005041868A2 Epidermal growth factor receptor modulation protects normal tissue
05/12/2005WO2005019432A3 A novel gene and protein associated with angiogenesis and endothelial apoptosis
05/12/2005WO2005019249A8 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005010152A3 Human mast cell-expressed membrane protein
05/12/2005WO2005005596A3 Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof
05/12/2005WO2004110370A3 Etiologic agnet for sow infertility syndrome
05/12/2005WO2004109291A3 Method for diagnosis and therapy of hazelnut-induced systemic reaction
05/12/2005WO2004104022A3 Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof
05/12/2005WO2004076631A3 Biologically active native biomatrix composition
05/12/2005WO2004072233A3 Hiv-specific fusion proteins and therapeutic and diagnostic methods for use
05/12/2005WO2004026899A9 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis b and the producing method and use thereof
05/12/2005WO2003022126A3 Compositions and methods for the therapy and diagnosis of colon cancer
05/12/2005WO2002072627A8 Induction of anti-tumor cytotoxic t-lymphocytes in humans using peptide epitopes found by computer based algorithms for vaccination
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101671 Compounds and compositions for delivering active agents
05/12/2005US20050101618 Selective erbB2 inhibitor/anti-erbB antibody combinations in the treatment of cancer
05/12/2005US20050101557 Immunostimulatory nucleic acid molecules
05/12/2005US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents
05/12/2005US20050101554 Methods for treating and preventing infectious disease
05/12/2005US20050101532 Protamine fragment compositions and methods of use
05/12/2005US20050101016 Recovering autoantibodies/blood protein via adjustment in redox states for use in constructing profile for diagnosing autoimmune disorders
05/12/2005US20050101000 Modulation of phosphodiesterase 4B expression
05/12/2005US20050100985 Saturation mutagenesis in directed evolution
05/12/2005US20050100984 Expression vector comprising nucleotide sequences coding immunoglobulin fusion directed towards tumors for use in treatment and prevention of cell proliferative disorders; tissue targeted therapy; immunotherapy
05/12/2005US20050100955 Immunoglobulin direceted towards colon specific gene (CSG) for use in classification, treatment and prevention of cell proliferative disorders; diagnostic imaging; gene expression inhibition; immunotherapy
05/12/2005US20050100928 Nucleotide sequences coding signal sequence segments comprising , tumor antigen, viral protein and structural protein sequences for use as tool in prevention, diagnosis and treatment of infection and cell proliferative disorders
05/12/2005US20050100918 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100917 Mammalian receptor proteins; related reagents and methods
05/12/2005US20050100901 Vaccine for treating nicotine addiction
05/12/2005US20050100896 Amino acid sequences comprising dombrook antigens for use as diagnostic tool in transfusion medicine; blood typing
05/12/2005US20050100895 Using conditionally replication-competent adenoviruses transcription as diagnostic indicator of cell proliferative disorders of alimentary canal; tissue targeted therapy; drug delivery
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100889 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
05/12/2005US20050100886 Nucleotide sequences coding dengu virus non-structural and west nile structural protein for use as tool in generating attenuated west nile viral vaccine
05/12/2005US20050100877 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpolulations and in cryopreservation, culture and transplantation of cells
05/12/2005US20050100611 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors
05/12/2005US20050100558 Heterologous boosting immunizations
05/12/2005US20050100557 Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
05/12/2005US20050100556 DNA viral vaccine fusion for use in prevention of viral infections and as a drug delivery tool
05/12/2005US20050100554 Chimeric polypeptides, vectors and cells; test for precancerous cells; human papilloma virus
05/12/2005US20050100552 Baculovirus vector, expressed in insect cells; induce apoptosis; introduced into tumor cell by viral vector, liposome, a conjugate, injection, electroporation, particle bombardment
05/12/2005US20050100551 Vaccine against cancerous diseases which is based on mimotopes of antigens expressed on tumor cells
05/12/2005US20050100545 Mutated antibody does not possess O-linked glycosylation, nucleic acids encoding prevents N-linked glycosylation; humanized and conjugated with radionucleotide to image target cells
05/12/2005US20050100544 Interleukin-8 homologous polypeptides and therapeutic uses thereof
05/12/2005US20050100543 Multivalent carriers of bi-specific antibodies
05/12/2005US20050100542 Cytotoxicity mediation of cells evidencing surface expression of CD44
05/12/2005US20050100541 Ligands, including antibodies, showing reactivity against endocrine cells
05/12/2005US20050100540 Platelet-activating factor acetylhydrolase
05/12/2005US20050100532 Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production
05/12/2005CA2544786A1 Method for producing gene transferred dendritic cells
05/12/2005CA2544708A1 Liver cancer biomarkers
05/12/2005CA2544365A1 Modified anti-cd52 antibody
05/12/2005CA2544298A1 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
05/12/2005CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005CA2543763A1 Bacterial virulence factors and uses thereof
05/12/2005CA2543538A1 Hbv variants detection and application
05/12/2005CA2543206A1 Method of antigen incorporation into neisseria bacterial outer membrane vesicles and resulting vaccine formulations
05/12/2005CA2543125A1 Colostrum compositions and methods
05/12/2005CA2543093A1 Therapeutic regimens for baff antagonists
05/12/2005CA2543080A1 Compositions and methods for activating innate and allergic immunity
05/12/2005CA2542840A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis
05/12/2005CA2542777A1 Stabilised compositions
05/12/2005CA2540949A1 C-class oligonucleotide analogs with enhanced immunostimulatory potency
05/12/2005CA2538695A1 Clq related protein
05/12/2005CA2536238A1 Humanization of antibodies
05/12/2005CA2534236A1 Lipoparticles comprising proteins, methods of making, and using the same
05/11/2005EP1529845A2 Fusion glycoprotein from HCMV and HSV
05/11/2005EP1529536A1 Immunogenic composition having improved immunostimulation capacity
05/11/2005EP1529527A2 Valproic acid for a combination treatment of human cancers, tumor metastasis and minimal residual disease
05/11/2005EP1529113A1 Vaccinia virus host range genes to increase the titer of avipoxviruses
05/11/2005EP1529107A2 Dna vaccines against hantavirus infections
05/11/2005EP1529064A2 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
05/11/2005EP1529062A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
05/11/2005EP1529060A2 Method for the production of an immunostimulating mucin (muc1)
05/11/2005EP1529054A2 Therapeutic protein and treatments
05/11/2005EP1529046A1 Substituted benzimidazole compounds
05/11/2005EP1528937A2 Nanoemulsion vaccines
05/11/2005EP1528936A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer
05/11/2005EP1528935A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
05/11/2005EP1528934A1 Use of antibodies against a tumor-associated antigen
05/11/2005EP1528915A2 Liposomal vaccine
05/11/2005EP1528914A1 Antigenic compositions
05/11/2005EP1326635B1 Pharmaceutical composition for immunisation against aids
05/11/2005EP1214416B1 Use of replication-deficient adenoviral vector in the manufacture of a medicament to boost cd8+ t cell immune response to antigen
05/11/2005EP1124575B1 Method for the production of an antiviral agent
05/11/2005EP1100771B1 Compounds and compositions for delivering active agents
05/11/2005EP0971737B1 Immunopotentiating formulations for vaccinal use
05/11/2005EP0625200B1 Biosynthetic binding protein for cancer marker
05/11/2005EP0572478B1 Hbgad and higad polypeptides and nucleic acids and their use for the diagnosis and treatment of gad autoantigen associated diseases
05/11/2005CN1615440A Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3
05/11/2005CN1615439A Genes encoding g-protein coupled receptors and methods of use therefor
05/11/2005CN1615364A HIV-1 virus tat-protein mutants
1 ... 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 ... 1823